Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ozempic (semaglutide)
Pharma
FDA orders GLP-1s add eye risk to labels
The FDA is ordering drugmakers to add a new and rare eye risk to the labels of 12 GLP-1s, including Zepbound and Ozempic.
Donavyn Coffey
Nov 10, 2026 8:31am
Novo reports strong Q3 for Wegovy pill as potential launches loom
Nov 4, 2026 11:26am
Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan
Sep 29, 2026 11:20am
Novo struggles to appease restless investors with new strategy
Sep 21, 2026 10:50am
Novo CEO talks embracing change and staying bullish amid rebrand
Sep 17, 2026 8:45am
No more Nordisk as Novo goes it alone amid rebranding push
Sep 14, 2026 6:54am
